GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Short Term Loans and Advances History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Loans and Advances | ₹1,075 Cr | ₹1,219 Cr | ₹908 Cr | ₹972 Cr | ₹700 Cr |
What is the latest Short Term Loans and Advances ratio of GLENMARK PHARMACEUTICALS ?
| Year | Short Term Loans and Advances |
|---|---|
| Mar2025 | ₹1,075 Cr |
| Mar2024 | ₹1,219 Cr |
| Mar2023 | ₹908 Cr |
| Mar2022 | ₹972 Cr |
| Mar2021 | ₹700 Cr |
How is Short Term Loans and Advances of GLENMARK PHARMACEUTICALS Trending?
| Years | Short Term Loans and Advances | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,075 Cr | -11.83 | |
| Mar2024 | ₹1,219 Cr | 34.26 | |
| Mar2023 | ₹908 Cr | -6.63 | |
| Mar2022 | ₹972 Cr | 38.82 | |
| Mar2021 | ₹700 Cr | - | |
Compare Short Term Loans and Advances of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹63,720.8 Cr | 6.4% | 15.4% | 62.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | 6.4% |
15.4% |
62.9% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses